FOXN3 and leukemia: A paradigm-shifting study on FOXN3 intron polyadenylation in leukemia that appeared in August 2018 in Nature discussed FOXN3 intron polyadenylation, and confirms that MYC is a direct repressive target of FOXN3 (35).